1. Home
  2. FXNC vs ELDN Comparison

FXNC vs ELDN Comparison

Compare FXNC & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$28.27

Market Cap

251.5M

Sector

Finance

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.88

Market Cap

300.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
ELDN
Founded
1907
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
251.5M
300.3M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
FXNC
ELDN
Price
$28.27
$3.88
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
62.4K
1.1M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
2.43%
N/A
EPS Growth
96.00
30.67
EPS
0.54
N/A
Revenue
$7,717,000.00
N/A
Revenue This Year
$12.21
N/A
Revenue Next Year
$2.93
N/A
P/E Ratio
$51.70
N/A
Revenue Growth
7.40
N/A
52 Week Low
$18.35
$1.35
52 Week High
$29.85
$4.60

Technical Indicators

Market Signals
Indicator
FXNC
ELDN
Relative Strength Index (RSI) 58.70 58.68
Support Level $26.39 $3.35
Resistance Level $28.66 $4.14
Average True Range (ATR) 0.79 0.21
MACD 0.12 -0.02
Stochastic Oscillator 82.48 65.07

Price Performance

Historical Comparison
FXNC
ELDN

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: